| Cumulative burden of colorectal cancer–associated genetic variants is more strongly associated with early-onset vs late-onset cancer AN Archambault, YR Su, J Jeon, M Thomas, Y Lin, DV Conti, AK Win, ... Gastroenterology 158 (5), 1274-1286. e12, 2020 | 162 | 2020 |
| Polypharmacy in older adults hospitalized for heart failure O Unlu, EB Levitan, E Reshetnyak, J Kneifati-Hayek, I Diaz, ... Circulation: Heart Failure 13 (11), e006977, 2020 | 150 | 2020 |
| Drosophila Muller F Elements Maintain a Distinct Set of Genomic Properties Over 40 Million Years of Evolution W Leung, CD Shaffer, LK Reed, ST Smith, W Barshop, W Dirkes, ... G3: Genes, Genomes, Genetics 5 (5), 719-740, 2015 | 109 | 2015 |
| Nongenetic determinants of risk for early-onset colorectal cancer AN Archambault, Y Lin, J Jeon, TA Harrison, DT Bishop, H Brenner, ... JNCI cancer spectrum 5 (3), pkab029, 2021 | 65 | 2021 |
| Risk stratification for early-onset colorectal cancer using a combination of genetic and environmental risk scores: an international multi-center study AN Archambault, J Jeon, Y Lin, M Thomas, TA Harrison, DT Bishop, ... JNCI: Journal of the National Cancer Institute 114 (4), 528-539, 2022 | 49 | 2022 |
| Prescribing patterns of heart failure-exacerbating medications following a heart failure hospitalization P Goyal, J Kneifati-Hayek, A Archambault, K Mehta, EB Levitan, L Chen, ... JACC: Heart Failure 8 (1), 25-34, 2020 | 33 | 2020 |
| What to expect that you’re not expecting: a pilot video education intervention to improve patient self-efficacy surrounding discharge medication barriers S Sinha, J Dillon, SK Dargar, A Archambault, P Martin, BA Frankel, JI Lee, ... Health informatics journal 25 (4), 1595-1605, 2019 | 26 | 2019 |
| Indications for β‐blocker prescriptions in heart failure with preserved ejection fraction B Yum, A Archambault, EB Levitan, T Dharamdasani, J Kneifati‐Hayek, ... Journal of the American Geriatrics Society 67 (7), 1461-1466, 2019 | 17 | 2019 |
| Impact of hospitalist-led interdisciplinary antimicrobial stewardship interventions at an academic medical center SJ Tang, R Gupta, JI Lee, AM Majid, P Patel, L Efird, A Loo, S Mazur, ... The Joint Commission Journal on Quality and Patient Safety 45 (3), 207-216, 2019 | 16 | 2019 |
| Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM) R Ferguson, A Archambault, D Simpson, L Morales, V Chat, E Kazlow, ... Scientific Reports 9 (1), 10173, 2019 | 10 | 2019 |
| Polypharmacy in older adults hospitalized for heart failure. Circ Heart Fail. 2020; 13 (11): e006977 O Unlu, EB Levitan, E Reshetnyak, J Kneifati-Hayek, I Diaz, ... | 6 | |
| Prescribing Patterns of Heart Failure-Exacerbating Medications Following a Heart Failure Hospitalization. JACC Hear Fail [Internet]. 2020 Jan; 8 (1): 25–34 P Goyal, J Kneifati-Hayek, A Archambault, K Mehta, EB Levitan, L Chen | 5 | |
| Polypharmacy increases in prevalence and severity following a heart failure hospitalization O Unlu, T Dharamdasani, A Archambault, I Diaz, L Chen, E Levitan, ... Journal of the American College of Cardiology 73 (9S1), 789-789, 2019 | 3 | 2019 |
| Reply: toward improved understanding of potential harm in heart failure P Goyal, J Kneifati-Hayek, A Archambault, K Mehta, EB Levitan, L Chen, ... Heart Failure 8 (3), 247-248, 2020 | 2 | 2020 |
| PATTERN OF β-BLOCKER USE FOLLOWING HOSPITALIZATION OF OLDER ADULTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) FROM THE REGARDS STUDY B Yum, A Archambault, J Kneifati-Hayek, L Chen, E Levitan, M Lachs, ... Journal of the American College of Cardiology 73 (9S1), 798-798, 2019 | 1 | 2019 |
| Incidence of any infections and SARS-CoV-2 infections in patients receiving treatment for follicular lymphoma and diffuse large B-cell lymphoma: Real-world evidence from a … OO Omofuma, A Breskin, P Shao, J Asubonteng, AN Archambault, ... Journal of Clinical Oncology 42 (16_suppl), e19061-e19061, 2024 | | 2024 |
| Incidence of Second Primary Malignancies in Medicare-Insured Patients in the US with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma S Ailawadhi, T Delea, A Moynahan, W Ge, C Hampp, A Archambault, ... Blood 142, 912, 2023 | | 2023 |
| SA35 Prognostic Factors and Effect Modifiers in Patients with Relapsed or Refractory Follicular Lymphoma Who Failed at Least 2 Lines of Therapy: A Systematic Literature Review Y Kuang, K Cantos, E Rashidi, J Uyei, A Archambault, Y Xu, C Hampp, ... Value in Health 26 (6), S403, 2023 | | 2023 |
| SA4 Prognostic Factors and Effect Modifiers in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Who Failed at Least 2 Prior Lines of Therapy: A Systematic … Y Kuang, K Cantos, E Rashidi, J Uyei, A Archambault, Y Xu, C Hampp, ... Value in Health 26 (6), S397, 2023 | | 2023 |
| Incidence of Second Primary Malignancies (SPMs) in Patients in the US with Triple-Class-Exposed (TCE) Relapsed or Refractory Multiple Myeloma (RRMM) W Ge, A Archambault, TE Delea, K Rodriguez Lorenc, J Harnett, ... Blood 140 (Supplement 1), 10897-10899, 2022 | | 2022 |
